Colgate-Palmolive
CL
87.21
-0.04
-0.05%
Colgate-Palmolive
US · CL
#335 by market cap
Listed 1970
87.21
-0.04
-0.05%
Live - 5344 symbols - heartbeat 78s ago
· 2026-10-08 04:00
Pre-market
87.21
0.00%
After-hours
87.21
0.00%
- Market cap
- 69.52B
- P/E (TTM)i
- 34.33
- P/Bi
- 294.63
- EPSi
- 2.63
- Div yieldi
- 2.40%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on CL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 86.03% -0.02pp
- Institutions
- 2,360 -7
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund71.23%
Public Company4.90%
Hedge Fund2.80%
Government Pension Fund2.42%
Private Company2.34%
Sovereign Wealth Fund1.32%
Family Office/Trust0.30%
Insurance Company0.27%
Corporate Pension Plan0.18%
Other14.25%
Top holders as of 2026-06-30
BlackRock
8.77% · 69.92M sh
Vanguard Capital Management, LLC
7.12% · 56.78M sh
State Street Global Advisors
5.90% · 47.02M sh
T. Rowe Price Group, Inc.
3.50% · 27.94M sh
Vanguard Portfolio Management, LLC
3.01% · 24.02M sh
Other
71.69%
Geode Capital Management, LLC
2.90% · 23.14M sh
Morgan Stanley
1.78% · 14.16M sh
BNY Mellon Asset Management
1.63% · 13.02M sh
Deutsche Asset & Wealth Management
1.45% · 11.53M sh
UBS Asset Management
1.33% · 10.56M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Noel Wallace | Chairperson & CEO | 0.06% |
| Jennifer Daniels | Chief Legal Officer | 0.01% |
| Panagiotis Tsourapas | Group President of Europe & Developing Markets | 0.01% |
| Stanley Sutula | Chief Financial Officer | 0.01% |
| Prabha Parameswaran | Group President of Growth & Strategy | 0.01% |
| John Cahill | Independent Director | 0.00% |
| John Hazlin | President of Hill’s Pet Nutrition | 0.00% |
| Shane Grant | Chief Operating Officer of Americas | 0.00% |
| C. Harris | Independent Director | 0.00% |
| Betsy Fishbone | Executive VP and Sr Assoc of GC HR Lit Comp & NA Ops | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Lorrie Norrington | Lead Independent Director | Other Acquisition | +300 | $87.42 |
| 2026-09-30 | John Paul Bilbrey | Independent Director | Other Acquisition | +271 | $87.42 |
| 2026-09-30 | Brian Newman | Director | Other Acquisition | +214 | $87.42 |
| 2026-09-15 | Noel Wallace | Chairperson & CEO | Other Acquisition | +29,649 | -- |
| 2026-09-15 | Noel Wallace | Chairperson & CEO | Other Derivative Acquisition | +205,197 | $87.02 |
| 2026-09-15 | Panagiotis Tsourapas | Group President of Europe & Developing Markets | Other Acquisition | +4,597 | -- |
| 2026-09-15 | Panagiotis Tsourapas | Group President of Europe & Developing Markets | Other Derivative Acquisition | +31,814 | $87.02 |
| 2026-09-15 | Stanley Sutula | Chief Financial Officer | Other Acquisition | +8,045 | -- |
| 2026-09-15 | Stanley Sutula | Chief Financial Officer | Other Derivative Acquisition | +55,674 | $87.02 |
| 2026-09-15 | Shane Grant | Chief Operating Officer of Americas | Other Acquisition | +7,355 | -- |
| 2026-09-15 | Shane Grant | Chief Operating Officer of Americas | Other Derivative Acquisition | +50,902 | $87.02 |
| 2026-09-15 | John Hazlin | President of Hill’s Pet Nutrition | Other Acquisition | +3,908 | -- |
| 2026-09-15 | John Hazlin | President of Hill’s Pet Nutrition | Other Derivative Acquisition | +27,042 | $87.02 |
| 2026-09-15 | Gregory Malcolm | Vice President | Other Acquisition | +1,081 | -- |
| 2026-09-15 | Gregory Malcolm | Vice President | Other Derivative Acquisition | +7,477 | $87.02 |
| 2026-09-15 | Sally Massey | Chief Human Resources Officer | Other Acquisition | +3,333 | -- |
| 2026-09-15 | Sally Massey | Chief Human Resources Officer | Other Derivative Acquisition | +23,065 | $87.02 |
| 2026-09-15 | Betsy Fishbone | Executive VP and Sr Assoc of GC HR Lit Comp & NA Ops | Other Acquisition | +2,207 | -- |
| 2026-09-15 | Betsy Fishbone | Executive VP and Sr Assoc of GC HR Lit Comp & NA Ops | Other Derivative Acquisition | +15,271 | $87.02 |
| 2026-09-12 | Noel Wallace | Chairperson & CEO | Sale to Issuer | -12,479 | $86.80 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:00:07 · For reference only, not investment advice and not tailored to your situation.